DelveEpiAI brings together DelveInsight's curated epidemiology data covering 500+ indications, ranging from major oncology diseases to rare niche orphan conditions. The platform integrates patient ...

Discover why biomarkers are critical in modern drug discovery and clinical trials, enabling better target validation.

Market segmentation, in which consumers are grouped into categories that then define how they are engaged and supported, is still a relatively new concept in healthcare, but can greatly benefit the ...

With the rise of consumerism in healthcare and new payment models like value-based purchasing, hospital leaders are taking a closer look at their approach to patient — or customer — experience. In the ...

Impact of IVS14+1G>A and 2846A>T DPYD polymorphisms on toxicity outcome of patients treated with fluoropyrimidine-containing regimens. This is an ASCO Meeting Abstract from the 2013 ASCO Annual ...

For decades, real-world data (RWD) has supplemented findings from clinical trials. It’s helped us understand drug utilization, efficacy, and adverse events that may not have been apparent during ...